State NC
Clinical Trials in North Carolina
Recruiting clinical trials with at least one study location in North Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in North Carolina
Frequently Asked Questions — Clinical Trials in North Carolina
How many clinical trials are currently recruiting in North Carolina?
ClinicalMetric currently tracks 396 actively recruiting clinical trials with at least one location in North Carolina. The total number of registered studies—including active but not currently enrolling trials—is 396. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in North Carolina?
North Carolina hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout North Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in North Carolina?
To join a clinical trial in North Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in North Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in North Carolina
NCT06249555 N/A
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With C...
Condition
Crohn's Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
Alimentiv Inc.
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cerebl...
Condition
Multiple Myeloma
Enrollment
135 pts
Location
United States, Australia, Canada
Sponsor
AbbVie
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05019625 N/A
Recruiting
Biomarker Development for Muscular Dystrophies
Condition
Myotonic Dystrophy
Enrollment
465 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT01137643 N/A
Recruiting
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic C...
Condition
Chronic Myeloproliferative Disorders
Enrollment
15,000 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C
NCT05169515 Phase 1
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab o...
Condition
Non-Hodgkin Lymphoma
Enrollment
121 pts
Location
United States, Israel, Italy
Sponsor
Hoffmann-La Roche
NCT05219617 Phase 3
Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizu...
Condition
Seizures
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
SK Life Science, Inc.
NCT06854718 N/A
Recruiting
Pain With Dementia
Condition
Pain
Enrollment
60 pts
Location
United States
Sponsor
Duke University
NCT06708897 Phase 1
Recruiting
A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leuk...
Condition
CLL / SLL
Enrollment
66 pts
Location
United States
Sponsor
Lomond Therapeutics Holdings,
NCT04655404 EARLY_Phase 1
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK F...
Condition
High Grade Glioma
Enrollment
15 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
164 pts
Location
United States, Argentina, Australia
Sponsor
Mediar Therapeutics
NCT06623669 Phase 2
Recruiting
A Mobile Intervention to Reduce Pain and Improve Health-III
Condition
Chronic Pain
Enrollment
200 pts
Location
United States
Sponsor
Wake Forest University
NCT05533697 Phase 1, Phase 2
Recruiting
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint ...
Condition
Advanced Solid Tumors
Enrollment
361 pts
Location
United States, Australia, Spain
Sponsor
ModernaTX, Inc.
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT07196241 N/A
Recruiting
Comprehensive Care for AYA: Needs Assessment Survey
Condition
Cancer
Enrollment
300 pts
Location
United States
Sponsor
Wake Forest University Health
NCT03310905 N/A
Recruiting
Abdominal Wall Transplant
Condition
Transplant;Failure,Kidney
Enrollment
5 pts
Location
United States
Sponsor
Duke University
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
NCT07015905 Phase 3
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee ...
Condition
Venous Thromboembolism (VTE)
Enrollment
2,000 pts
Location
United States, Bulgaria, Hungary
Sponsor
Regeneron Pharmaceuticals
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
NCT07021040 N/A
Recruiting
Olfactory Biopsies
Condition
Alzheimer Disease
Enrollment
125 pts
Location
United States
Sponsor
Duke University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology